References

Home

1. Frampton GM et al. Nat Biotechnol 2013; 31: 1023-1031.

2. Drilon A et al. Clin Cancer Res 2015; 21: 3631-3639.

3. Rankin A et al. Oncologist 2016; 21: 1306-1314.

4. Ross JS et al. Cancer 2016; 122: 2654-2662.

5. Suh JH et al. Oncologist 2016; 21: 684-691.

6. Hirshfield KM et al. Oncologist 2016; 21: 1315-1325.

7. FoundationOne®CDx Technical Specifications 2018. Available at:
www.rochefoundationmedicine.com/f1cdxtech (Accessed April 2019).

8. FoundationOne®CDx FDA Approval, 2017. Available at:
https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170019a.pdf (Accessed April 2019).

9. FoundationOne®Liquid Technical Specifications, 2018. Available at:
https://www.foundationmedicine.com/genomic-testing/foundation-one-liquid (Accessed April 2019).

10. FoundationOne®Heme Technical Specifications, 2017. Available at:
www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed April 2019).

11. Roche Media Release, 2018. Available at:
https://www.roche.com/media/releases/med-cor-2018-06-19.htm (Accessed April 2019).

12. He J et al. Blood 2016; 127: 3004-3014.

13. Clark TA et al. J Mol Diagn. 2018; 20: 686-702.

14. FoundationOne®CDx Sample Report, 2018. Available at: www.rochefoundationmedicine.com/reporting (Accessed April 2019).

What We Do

1. Frampton GM et al. Nat Biotechnol 2013; 31: 1023-1031.

2. Drilon A et al. Clin Cancer Res 2015; 21: 3631-3639.

3. Rankin A et al. Oncologist 2016; 21: 1306-1314.

4. Ross JS et al. Cancer 2016; 122: 2654-2662.

5. Suh JH et al. Oncologist 2016; 21: 684-691.

6. Hirshfield KM et al. Oncologist 2016; 21: 1315-1325.

7. FoundationOne®CDx Technical Specifications 2018. Available at:
www.rochefoundationmedicine.com/f1cdxtech (Accessed April 2019).

8. FoundationOne®Liquid Technical Specifications, 2018. Available at:
https://www.foundationmedicine.com/genomic-testing/foundation-one-liquid (Accessed April 2019).

9. FoundationOne®Heme Technical Specifications, 2017. Available at:
www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed April 2019).

10. He J et al. Blood 2016; 127: 3004-3014.

11. Clark TA et al. J Mol Diagn 2018; 20: 686-702.

12. Chalmers ZR et al. Genome Med 2017; 9: 34.

13. Rozenblum AB et al. J Thorac Oncol 2017; 12: 258-268.

14. Schrock AB et al. Clin Cancer Res 2016; 22: 3281-3285.

15. Ross JS et al. Gynecol Oncol 2013; 130: 554-559.

16. Hall MJ et al. J Clin Oncol 2016; 34: 1523-1523.

17. Le DT et al. Science. 2017; 357: 409-413.

18. Goodman AM et al. Mol Cancer Ther 2017; 16: 2598-2608.

19. Dudley JC et al. Clin Cancer Res 2016; 22: 813-820.

20. Johnson DB et al. Cancer Immunol Res 2016; 4: 959-967.

21. Rizvi H et al. J Clin Oncol 2018; 36: 633-641.

22. Hellmann MD et al. N Engl J Med 2018; 378: 2093-2104.

23. FoundationOne®CDx Sample Report, 2018. Available at:
www.rochefoundationmedicine.com/reporting (Accessed April 2019).

24. A search for “Foundation Medicine”[Affiliation] on the NCBI database resulted in 348 publications, as of October 2018. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/?term=%E2%80%9CFoundation+Medicine%E2%80%9D%5BAffiliation%5D (Accessed April 2019).

25. Foundation Medicine Publications. Available at:
https://www.foundationmedicine.com/publications (Accessed April 2019).

26. Foundation Insights. Available at:
https://www.foundationmedicine.com/insights-and-trials/foundation-insights. (Accessed April 2019).

Our Services

1. FoundationOne®CDx Technical Specifications 2018. Available at:
www.rochefoundationmedicine.com/f1cdxtech (Accessed April 2019).

2. FoundationOne®CDx FDA Approval, 2017. Available at:
https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170019a.pdf (Accessed April 2019).

3. FoundationOne®Liquid Technical Specifications, 2018. Available at:
https://www.foundationmedicine.com/genomic-testing/foundation-one-liquid (Accessed April 2019).

4. FoundationOne®Heme Technical Specifications, 2017. Available at:
www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed April 2019).

5. FoundationOne®CDx FDA Approval Press Release, 2017. Available at:
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm587273.htm (Accessed April 2019).

6. FoundationOne®CDx clinical validation, 2017. Available at:
http://www.foundationmedicine.com/genomic-testing/foundation-one-cdx (Accessed April 2019).

7. Frampton GM et al. Nat Biotechnol 2013; 31: 1023–1031.

8. Drilon A et al. Clin Cancer Res 2015; 21: 3631–3639.

9. Rankin A et al. Oncologist 2016; 21: 1306–1314.

10. Ross JS et al. Cancer 2016; 122: 2654–2662.

11. Suh JH et al. Oncologist 2016; 21: 684–691.

12. Hirshfield KM et al. Oncologist 2016; 21: 1315–1325.

13. Clark TA et al. J Mol Diagn. 2018; 20: 686–702.

About Us

1. Roche Media Release, 2018. Available at:
https://www.roche.com/media/releases/med-cor-2018-06-19.htm (Accessed April 2019).

2. Foundation Insights. Available at:
https://www.foundationmedicine.com/insights-and-trials/foundation-insights. (Accessed April 2019).

3. A search for “Foundation Medicine”[Affiliation] on the NCBI database resulted in 348 publications, as of October 2018. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/?term=%E2%80%9CFoundation+Medicine%E2%80%9D%5BAffiliation%5D (Accessed April 2019).

4. Foundation Medicine Publications. Available at:
https://www.foundationmedicine.com/publications (Accessed April 2019).